Globally, diabetes is the fourth most death causing disease. According to International Diabetes Federation, every year seven million people get effected by diabetes and about 3.8 million people die every year due to diabetes and even more people die due to chronic diseases caused by diabetes Diabetes is a group of metabolic disorders, chronic condition which is associated with abnormally high level of sugar (glucose) in the blood. South- East Asia currently witnesses 78.3 million people affected with Diabetes which is going to reach 140.2 million by 2040. Western Pacific region witnesses 153.2 million people affected with diabetes and this number is said to reach 214.8 million by 2040.
Asia-Pacific Diabetes Care Devices Market: Drivers & Restraints Asia Pacific is the region with the highest population of diabetes effected people and the number is increasing quite rapidly which is the major driving force of the market. Also, the increasing healthcare costs is driving the market with increased revenues accumulated by the companies in this region. But the market growth is constrained here due to low medical literacy rate which is leading to the fall in sales of devices.
Asia-Pacific Diabetes Care Devices Market: Segmentation By Type Glucose Monitoring Devices o Self-Blood Glucose Monitoring Devices Glucose Meters Test Strips Lancets Hemoglobin A1c testing Kits o Continuous Glucose Monitoring Devices Insulin Delivery Systems o Insulin Syringes o Insulin Pens o Insulin Pumps o Jet Injectors
Asia-Pacific Diabetes Care Devices Market: Overview Glucose monitoring devices holds the largest share in the market due to prevalence of diabetes and extensive use of these devices in hospitals and clinics to monitor the patients condition. Insulin delivery devices are expected to grow the fastest due to rapidly growing home healthcare systems.
Asia-Pacific Diabetes Care Devices Market: Region-wise Outlook China had the largest number of diabetic patients with around 96.2 million diabetic patients followed by India with around 66.8 million diabetic patients in 2014. This represents a majority of approximately 40-45% of the global diabetic population living in India and China, providing significant opportunities for the global diabetes care devices companies to invest in this region.
Key Questions Answered What is the current and future Diabetes Care Devices Market outlook in Asia-Pacific? What trends are affecting the market? What is the competitive landscape and market share of major players in the Diabetes Care Devices Market space in Asia-Pacific? What are the key, high growth markets that Diabetes Care Devices Market manufacturers should expand into? Which market segments are growing the fastest? What are the unmet needs with the Diabetes Care Devices currently on the market? How will emerging technologies fulfil these unmet needs? What is patient perception and market outlook of Diabetes Care Devices? What are the challenges and barriers that have hindered widespread adoption of Diabetes Care Devices?
Asia-Pacific Diabetes Care Devices Market: Key Players Roche Diagnostics, Ascensia, Abbott Laboratories, Novo Nordisk, Johnson & Johnson, Tandem and Terumo are the top companies in Asia-Pacific Diabetes Care Devices Market.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.